Description

Atazanavir Sulfate is a second-generation protease inhibitor originally developed under the brand name Reyataz®. The 300?mg capsule by Aurobindo Pharma is a generic equivalent authorized under NMPA standards (China) and U.S. FDA ANDA status. It functions by inhibiting HIV?1 protease enzyme, thereby reducing viral replication. Widely used in pharmaceutical distribution and HIV research studies.

This product is sold as a bottle of 30 capsules at 300?mg strength, suitable for research, formulation, or bulk procurement use.

Atazanavir Sulfate Capsules Product Parameters

Atazanavir Sulfate Capsules Mechanism of Action
Atazanavir inhibits the HIV?1 protease, an enzyme essential for viral maturation. By preventing cleavage of viral polyproteins, it disrupts the production of mature viral particles, lowering viral load in infected systems. The generic version retains equivalent pharmacological action.

Atazanavir Sulfate Capsules Potential Side Effects (for research context)

• Mild elevations in bilirubin (hyperbilirubinemia)

• Gastrointestinal discomfort

• Potential changes in lipid or blood glucose profiles in in vivo studies

These effects reflect observations in clinical contexts but may be informative in pharmacological and pharmacokinetic research settings.

Keywords

• Atazanavir sulfate capsules 300?mg wholesale

• Aurobindo atazanavir generic

• Protease inhibitor research compound

• Atazanavir bulk supply

• HIV drug for lab use

Disclaimer
This product is provided for laboratory or formulation research use only. It is not intended for clinical, diagnostic, or therapeutic use in humans or animals. Buyers must abide by applicable laws and ensure proper handling and regulatory compliance.